IP Library Granted Patent US 7,966,072
Granted Patent B2
US 7,966,072 · App. 11/344,586 · Granted Jun 21, 2011

Methods and compositions for treating obesity-hypoventilation syndrome

Assignee: Palo Alto Investors
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,966,072
App. No.
11/344,586
Granted
Jun 21, 2011
Kind
B2
Abstract

Methods and compositions for treating a subject for obesity-hypoventilation syndrome, or related conditions, are provided. The subject methods include applying an electrical stimulus to a subject in a manner that modulates chest cavity capacity in a manner effective to treat the subject. Also provided are compositions, kits and systems for use in practicing the subject methods.

Claims (13)

1. A method of treating a subject for obesity-hypoventilation syndrome (OHS), said method comprising:

providing a subject diagnosed with OHS, wherein the subject has persistence of hypercapnic respiratory failure with a PCO 2 >47 mmHg for at least three months, a body mass index greater than 33, an apnea-hypopnea index (AHI) measured from a complete polysomnographic study of less than 20 events per hour, and a forced expiratory volume/forced vital capacity (FEV 1 /FVC ratio above 0.65; and

treating said subject for OHS by applying an electrical stimulus to:

a diaphragm target site, wherein the stimulus enhances diaphragm contraction during expiration and the stimulus enhances diaphragm relaxation during inspiration; and

a chest wall target site, wherein the stimulus enhances chest cavity capacity during inspiration and reduces chest cavity capacity during expiration.

2. The method according to claim 1 , wherein said method comprises applying the electrical stimulus to said chest wall target site to enhance chest wall contraction.

3. The method according to claim 1 , wherein said electrical stimulus is continuous.

4. The method according to claim 1 , wherein said electrical stimulus is from an implanted intramuscular electrode adjacent to a point of termination of the corresponding motor nerve supply for the muscle at said target site.

5. The method according to claim 1 , wherein said method further comprises synchronizing said electrical stimulus of said at least one target site with said subject's own attempts at breathing.

6. The method according to claim 1 , wherein the electrical stimulation of the diaphragm and chest wall target sites is performed to achieve the maximum possible total lung capacity for said subject.

7. The method according to claim 1 , wherein said electrical stimulus is applied during expiration to inhibit native electrical stimulation of the diaphragm.

8. The method according to claim 1 , wherein said electrical stimulus is applied during expiration to inhibit native electrical stimulation of said subject's chest wall muscles.

9. The method according to claim 1 , wherein dietetic treatment has failed to induce weight loss in said subject for at least 3 months.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2006
From: YUN, ANTHONY JOONKYOO; LEE, PATRICK YUARN-BOR
To: PALO ALTO INVESTORS
Reel/Frame 017754/0140 →
Continuity (2)
Provisional Application 60654139 · Feb 18, 2005
Related Publication 20060190052A1 · Aug 24, 2006